Keyphrases
Bilateral Retinoblastoma
13%
Blindness
27%
Cataract
15%
Causes of Blindness
31%
Childhood Blindness
12%
Clinical Characteristics
19%
Confidence Interval
10%
Conjunctival Swab
10%
Corticosteroids
16%
COVID-19
20%
COVID-19 Pandemic
10%
Developing Countries
23%
Distance Vision
25%
Enucleation
13%
Extraocular
26%
Global Burden of Disease Study
19%
Indonesia
89%
Jakarta
32%
Leber Congenital Amaurosis
10%
Leukocoria
10%
Low-income Countries
12%
Low-middle Income Countries
10%
Meta-analysis
19%
National Income Level
10%
Near Vision Impairment
19%
Odds Ratio
14%
Old Age
11%
Population Survey
11%
Posterior Staphyloma
10%
Preterm Infants
19%
Prevalence of Blindness
16%
Preventable Blindness
10%
Referral Hospital
12%
Refractive Error
11%
Retinal Changes
13%
Retinal Findings
9%
Retinoblastoma
100%
Retinopathy of Prematurity
33%
Risk Factors
26%
Schools for the Blind
16%
Severe Visual Impairment
20%
Survival Rate
16%
Systematic Meta-analysis
19%
Temporal Trends
16%
Treatment Outcome
9%
Tumor
20%
Tumor Extension
11%
Uncertainty Interval
13%
Vision Impairment
28%
β-Thalassemia (β-thal)
16%
Medicine and Dentistry
Agents Acting on the Eye
7%
Amblyopia
8%
Bacterium Colony
8%
Bevacizumab
8%
Cancer Staging
8%
Cataract
14%
Childhood Blindness
16%
Chloramphenicol
8%
Cohort Analysis
8%
Computer Assisted Tomography
8%
Congenital Rubella Syndrome
8%
Coronavirinae
8%
COVID-19
25%
Cross Sectional Study
11%
Diseases
25%
DNA Polymorphism
8%
Dystrophy
8%
Enucleation
9%
Eye Disease
7%
Eye Injury
8%
Eye Ointment
8%
Ferritin
8%
Genetic Disorder
7%
Global Disease Burden
12%
Illness Behavior
8%
Intraarterial Drug Administration
8%
Leber Congenital Amaurosis
12%
Malignant Neoplasm
10%
Meta-Analysis
18%
Neonatal Infant
18%
Neoplasm
24%
Nephrotic Syndrome
8%
Norrie Disease
8%
Ocular Surface
8%
Patient Referral
13%
Pediatrics
12%
Povidone Iodine
8%
Prevalence
19%
Psychological Well-Being
8%
Refractive Error
14%
Retinal Haemorrhage
8%
Retinoblastoma
75%
Retinopathy of Prematurity
33%
Staphyloma
12%
Subcapsular Cataract
8%
Systematic Review
18%
Thalassemia Major
8%
Therapy Delay
8%
Visual Acuity
11%
Visual Impairment
50%
